183 filings
Page 5 of 10
8-K
748six0byow35ts6
31 Oct 22
AURORA study designed to evaluate bitopertin as a potential disease-modifying treatment for adults with EPP in the United States
9:05am
SEC STAFF LETTER
bmuz2x
28 Oct 22
SEC staff letter
12:00am
UPLOAD
jolitendlpw7fx3 8zb2
27 Oct 22
Letter from SEC
12:00am
CORRESP
v7li1ud
7 Oct 22
Correspondence with SEC
12:00am
UPLOAD
b05m9ig8
3 Oct 22
Letter from SEC
12:00am
425
j0b2crc9c 64c1z23
10 Aug 22
Business combination disclosure
5:12pm
8-K
7ucfahnzwmut
10 Aug 22
Conference Call Transcript
5:10pm
8-K
qdl5ap 8kz4e
10 Aug 22
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
12:00am
425
9hiwi
10 Aug 22
Business combination disclosure
12:00am
8-K
bajcg
5 Apr 22
Departure of Directors or Certain Officers
8:00am
EFFECT
uabe6q5bax hx
15 Mar 22
Notice of effectiveness
12:15am
POS AM
vp1e7ugmx8km839k di
10 Mar 22
Prospectus update (post-effective amendment)
8:39pm
S-8
j37w kglp0mhx
10 Mar 22
Registration of securities for employees
7:35am
POS AM
qjnf0es0c8it0d3ur
10 Mar 22
Prospectus update (post-effective amendment)
7:31am
8-K
kuhsnzk j7zv67qxd4ag
10 Mar 22
Gemini Therapeutics Reports 2021 Financial Results
7:05am